The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
ELA - European Association Against Leukodystrophies
2, rue Mi-les-Vignes
Laxou Cedex, 61024
The ELA is an association of motivated and informed parents and patients who share responsibilities within ELA and have united their efforts in order to fight leukodystrophies and myelin diseases. Their goals are to help and support families affected by leukodystrophy, stimulate research, and raise public awareness. ELA also forms part of an international network of information and research into myeline diseases. Leukodystrophy is a group of rare, genetic diseases that destroy the central nervous system. Significant impairment of physical and mental abilities is usually present in individuals with this disease. Other symptoms are specific to the type of leukodystrophy.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.